These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3263352)

  • 1. In-vitro activity and beta-lactamase stability of LY163892.
    Cao C; Chin NX; Neu HC
    J Antimicrob Chemother; 1988 Aug; 22(2):155-65. PubMed ID: 3263352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity and beta-lactamase stability of the new oral cephalosporin Bay v 3522.
    Chin NX; Gu JW; Neu HC
    Eur J Clin Microbiol Infect Dis; 1990 Sep; 9(9):685-91. PubMed ID: 2226499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.
    Chin NX; Neu HC
    Antimicrob Agents Chemother; 1988 May; 32(5):671-7. PubMed ID: 3260766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in-vitro activity of a new oral carbacephem, LY163892.
    Howard AJ; Dunkin KT
    J Antimicrob Chemother; 1988 Oct; 22(4):445-56. PubMed ID: 3060458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro activity and beta-lactamase stability of FK482, a new oral cephalosporin.
    Neu HC; Saha G; Chin NX
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1795-800. PubMed ID: 2589845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity of LY163892, an orally administered 1-carbacephem.
    Jones RN; Barry AL
    J Antimicrob Chemother; 1988 Sep; 22(3):315-20. PubMed ID: 3182429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro activity and beta-lactamase stability of FR 17027, a new orally active cephalosporin.
    Neu HC; Chin NX; Labthavikul P
    Antimicrob Agents Chemother; 1984 Aug; 26(2):174-80. PubMed ID: 6333207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro activity and beta-lactamase stability of RU29246, the active metabolite of HR916B.
    Yu KW; Chin NX; Neu HC
    Eur J Clin Microbiol Infect Dis; 1992 Jul; 11(7):652-9. PubMed ID: 1396779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMY-28100, a new oral cephalosporin: antimicrobial activity against nearly 7,000 recent clinical isolates, comparative potency with other oral agents, and activity against beta-lactamase producing isolates.
    Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1988 Jan; 9(1):11-26. PubMed ID: 3259489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity and beta-lactamase stability of LY163892.
    Pelosi E; Fontana R
    Eur J Clin Microbiol Infect Dis; 1988 Aug; 7(4):549-51. PubMed ID: 3141170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity and beta-lactamase stability of two oral cephalosporins, ceftetrame (Ro 19-5247) and cefetamet (Ro 15-8074).
    Neu HC; Chin NX; Labthavikul P
    Antimicrob Agents Chemother; 1986 Sep; 30(3):423-8. PubMed ID: 3490827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity and beta-lactamase stability of a new penem, CGP 31608.
    Neu HC; Chin NX; Neu NM
    Antimicrob Agents Chemother; 1987 Apr; 31(4):558-69. PubMed ID: 3496845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial activity and beta-lactamase stability of MDL 19,592, an oral cephalosporin.
    Yu KW; Neu HC
    Diagn Microbiol Infect Dis; 1989; 12(5):441-3. PubMed ID: 2515027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of cefcanel versus other oral cephalosporins.
    Chin NX; Gu JW; Neu HC
    Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):676-82. PubMed ID: 1748125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibilities of common pediatric pathogens to LY163892.
    Shelton S; Nelson JD
    Antimicrob Agents Chemother; 1988 Feb; 32(2):268-70. PubMed ID: 3129989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial activity and beta-lactamase stability of BMY-28232, parent compound of an oral cephalosporin.
    Chin NX; Yu KW; Neu HC
    Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):841-6. PubMed ID: 2086221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production.
    Blandino G; Aleo G; Caccamo F; Nicolosi VM; Siracusa V; Speciale A
    J Chemother; 1996 Jun; 8(3):193-9. PubMed ID: 8808715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in-vitro activity of cefdinir (FK482), a new oral cephalosporin.
    Wise R; Andrews JM; Thornber D
    J Antimicrob Chemother; 1991 Aug; 28(2):239-48. PubMed ID: 1778855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of BAY v 3522, a new oral cephalosporin.
    Fass RJ
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1855-7. PubMed ID: 2126697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity and susceptibility to hydrolysis of S-1006.
    Neu HC; Gu JW; Fang W; Chin NX
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1336-41. PubMed ID: 1416835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.